2 results  1 of 1 

1 An open-label, multicenter, phase I trial of a cremophor-free, polymeric micelle formulation of paclitaxel combined with carboplatin as a first-line treatment for advanced ovarian cancer: a Korean Gynecologic Oncology Group study (KGOG-3016)
Shin-Wha Lee, Yong-Man Kim, Young Tae Kim, Soon Beom Kang
J Gynecol Oncol.2017;28(3):e26.  Published online 2016 December 19     DOI: http://dx.doi.org/10.3802/jgo.2017.28.e26
      
2 B-cell Complement Dependent Cytotoxic Crossmatch Positivity is an Independent Risk Factor for Long-term Renal Allograft Survival
Hyeon Seok Hwang, Hye Eun Yoon, Bum Soon Choi, Eun Jee Oh, Ji Il Kim, In Sung Moon, Yong Soo Kim, Chul Woo Yang
J Korean Med Sci.2011;26(4):528-533.   Published online 2011 March 28     DOI: http://dx.doi.org/10.3346/jkms.2011.26.4.528
      

 1 of 1